Investigation into Lipid Management in Acute Coronary Syndrome Patients from the EXPLORE-J Study.


Journal

Journal of atherosclerosis and thrombosis
ISSN: 1880-3873
Titre abrégé: J Atheroscler Thromb
Pays: Japan
ID NLM: 9506298

Informations de publication

Date de publication:
01 Jun 2019
Historique:
pubmed: 7 12 2018
medline: 4 12 2019
entrez: 7 12 2018
Statut: ppublish

Résumé

The EXPLORE-J study aimed to assess lipid management in patients hospitalized for acute coronary syndrome (ACS) and their cardiovascular risk despite undergoing standard therapy. Here, we focused on background characteristics of patients in the EXPLORE-J study to elucidate the current lipid-lowering therapy and its issues in Japan. In this multicenter, prospective, observational study (UMIN000018946), consecutive Japanese ACS patients who required hospitalization were registered between April 2015 and August 2016. Background and lipid profile data collected within 14 days of hospitalization were analyzed according to risk factors such as diabetes mellitus status. In total, 1944 patients were analyzed (80.3% male). The mean and standard deviation (SD) age and body mass index of all patients were 66.0 years (SD: 12.2) and 24.24 kg/m Many patients were not meeting Japanese LDL-C target levels at the time of ACS, and a large proportion of patients meeting target levels developed ACS; therefore, more stringent management and further evaluation of the target LDL-C levels is warranted in high-risk patients and those with previous history of CAD.

Identifiants

pubmed: 30518728
doi: 10.5551/jat.45583
pmc: PMC6545456
doi:

Substances chimiques

Anticholesteremic Agents 0
Biomarkers 0
Cholesterol, LDL 0
Lipids 0

Types de publication

Journal Article Multicenter Study Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

559-572

Références

Circulation. 2004 Jul 13;110(2):227-39
pubmed: 15249516
Lancet. 2005 Oct 8;366(9493):1267-78
pubmed: 16214597
JAMA. 2008 Apr 9;299(14):1678-89
pubmed: 18398080
J Am Coll Cardiol. 2008 Jul 1;52(1):71-9
pubmed: 18582638
Cardiovasc Drugs Ther. 2010 Feb;24(1):77-83
pubmed: 20352313
J Atheroscler Thromb. 2011;18(2):83-8
pubmed: 21307610
Eur Heart J. 2011 Jul;32(14):1769-818
pubmed: 21712404
EPMA J. 2011 Mar;2(1):49-57
pubmed: 23199126
PLoS One. 2013 Sep 06;8(9):e74699
pubmed: 24040326
Circulation. 2014 Jun 24;129(25 Suppl 2):S1-45
pubmed: 24222016
J Atheroscler Thromb. 2014;21(8):784-98
pubmed: 24671110
Am J Epidemiol. 2014 Jun 1;179(11):1293-300
pubmed: 24743066
J Atheroscler Thromb. 2015;22(12):1287-304
pubmed: 26289083
JAMA. 2016 Sep 27;316(12):1289-97
pubmed: 27673306
BMJ Open. 2017 Jul 2;7(6):e014427
pubmed: 28674132
Cardiovasc Diabetol. 2017 Oct 2;16(1):123
pubmed: 28969633
J Atheroscler Thromb. 2018 Apr 1;25(4):308-322
pubmed: 29238010
J Atheroscler Thromb. 2018 Jul 1;25(7):606-620
pubmed: 29321397
J Atheroscler Thromb. 2018 Apr 1;25(4):304-305
pubmed: 29467342
J Atheroscler Thromb. 2018 Sep 1;25(9):846-984
pubmed: 30135334

Auteurs

Masato Nakamura (M)

Division of Cardiovascular Medicine, Toho University Ohashi Medical Center.

Junya Ako (J)

Department of Cardiovascular Medicine, Kitasato University.

Hidenori Arai (H)

Department of Geriatric Medicine, National Center for Geriatrics and Gerontology.

Atsushi Hirayama (A)

Cardiovascular Division, Osaka Police Hospital.

Yoshitaka Murakami (Y)

Department of Medical Statistics, Toho University.

Atsushi Nohara (A)

Department of Lipidology, Kanazawa University of Graduate School of Medical Sciences.

Kiyoko Uno (K)

Cardiovascular Medical, Diabetes & Cardiovascular Medical Operations, Sanofi.

Asuka Ozaki (A)

Cardiovascular Medical, Diabetes & Cardiovascular Medical Operations, Sanofi.

Mariko Harada-Shiba (M)

Department of Molecular Innovation in Lipidology, National Cerebral & Cardiovascular Center Research Institute.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH